251 related articles for article (PubMed ID: 16431002)
1. Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial.
Ikematsu H; Nakamura K; Harashima S; Fujii K; Fukutomi N
Regul Toxicol Pharmacol; 2006 Apr; 44(3):212-8. PubMed ID: 16431002
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment for coenzyme Q10 (Ubiquinone).
Hathcock JN; Shao A
Regul Toxicol Pharmacol; 2006 Aug; 45(3):282-8. PubMed ID: 16814438
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
Storch A; Jost WH; Vieregge P; Spiegel J; Greulich W; Durner J; Müller T; Kupsch A; Henningsen H; Oertel WH; Fuchs G; Kuhn W; Niklowitz P; Koch R; Herting B; Reichmann H;
Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
[TBL] [Abstract][Full Text] [Related]
4. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers.
Hosoe K; Kitano M; Kishida H; Kubo H; Fujii K; Kitahara M
Regul Toxicol Pharmacol; 2007 Feb; 47(1):19-28. PubMed ID: 16919858
[TBL] [Abstract][Full Text] [Related]
5. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system.
Liu ZX; Artmann C
Altern Ther Health Med; 2009; 15(2):42-6. PubMed ID: 19284181
[TBL] [Abstract][Full Text] [Related]
6. Electrocardiographic and hemodynamic effects of coenzyme Q10 in healthy individuals: a double-blind, randomized controlled trial.
Shah SA; Sander S; Cios D; Lipeika J; Kluger J; White CM
Ann Pharmacother; 2007 Mar; 41(3):420-5. PubMed ID: 17341532
[TBL] [Abstract][Full Text] [Related]
7. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
9. Plasma ubiquinone status and response to six-month supplementation combined with multivitamins in healthy elderly women--results of a randomized, double-blind, placebo-controlled study.
Wolters M; Hahn A
Int J Vitam Nutr Res; 2003 May; 73(3):207-14. PubMed ID: 12847998
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10).
Schulz C; Obermüller-Jevic UC; Hasselwander O; Bernhardt J; Biesalski HK
Int J Food Sci Nutr; 2006; 57(7-8):546-55. PubMed ID: 17162333
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial].
Engelsen J; Nielsen JD; Hansen KF
Ugeskr Laeger; 2003 Apr; 165(18):1868-71. PubMed ID: 12772396
[TBL] [Abstract][Full Text] [Related]
13. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study.
Tiano L; Belardinelli R; Carnevali P; Principi F; Seddaiu G; Littarru GP
Eur Heart J; 2007 Sep; 28(18):2249-55. PubMed ID: 17644511
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
15. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
[TBL] [Abstract][Full Text] [Related]
16. Effects of coenzyme Q10 supplementation on plasma adiponectin, interleukin-6, and tumor necrosis factor-alpha levels in men.
Gökbel H; Gergerlioğlu HS; Okudan N; Gül I; Büyükbaş S; Belviranli M
J Med Food; 2010 Feb; 13(1):216-8. PubMed ID: 20136458
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
[TBL] [Abstract][Full Text] [Related]
18. Coenzyme Q10 absorption and tolerance in children with Down syndrome: a dose-ranging trial.
Miles MV; Patterson BJ; Schapiro MB; Hickey FJ; Chalfonte-Evans M; Horn PS; Hotze SL
Pediatr Neurol; 2006 Jul; 35(1):30-7. PubMed ID: 16814082
[TBL] [Abstract][Full Text] [Related]
19. Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study.
Hoenjet KM; Dagnelie PC; Delaere KP; Wijckmans NE; Zambon JV; Oosterhof GO
Eur Urol; 2005 Apr; 47(4):433-9; discussion 439-40. PubMed ID: 15774238
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
